COVID-19 Outbreak-Global Nonalcoholic Steatohepatitis (Nash) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

December 2020 | 120 pages | ID: C56281466A44EN
Maia Research

Abstracts

The Nonalcoholic Steatohepatitis (Nash) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Nonalcoholic Steatohepatitis (Nash) industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Nonalcoholic Steatohepatitis (Nash) market can be split based on product types, major applications, and important countries as follows:

Key players in the global Nonalcoholic Steatohepatitis (Nash) market covered in Chapter 12:

Tobira Therapeutics, Inc.
Cerenis Therapeutics
Connexios Life Sciences
Verva Pharmaceuticals
GENFIT SA
Immuron Ltd
Galmed Pharmaceuticals Ltd.
Boehringer Ingelheim
Novo Nordisk
Enzo Biochem, Inc
Gilead Science
Viking Therapeutics
Islet Sciences
Nimbus Therapeutics
Intercepts Pharmaceuticals
Astazeneca Plc
Genfit

In Chapter 4 and 14.1, on the basis of types, the Nonalcoholic Steatohepatitis (Nash) market from 2015 to 2025 is primarily split into:

Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Other Agents

In Chapter 5 and 14.2, on the basis of applications, the Nonalcoholic Steatohepatitis (Nash) market from 2015 to 2025 covers:

Phase I
Phase II
Phase III
Clinical Trials

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 NONALCOHOLIC STEATOHEPATITIS (NASH) INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Nonalcoholic Steatohepatitis (Nash)
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Nonalcoholic Steatohepatitis (Nash) industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Nonalcoholic Steatohepatitis (Nash) Market Size, 2015 – 2020
  2.1.2 Global Nonalcoholic Steatohepatitis (Nash) Market Size by Type, 2015 – 2020
  2.1.3 Global Nonalcoholic Steatohepatitis (Nash) Market Size by Application, 2015 – 2020
  2.1.4 Global Nonalcoholic Steatohepatitis (Nash) Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Nonalcoholic Steatohepatitis (Nash) Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Nonalcoholic Steatohepatitis (Nash) Analysis
3.2 Major Players of Nonalcoholic Steatohepatitis (Nash)
3.3 Nonalcoholic Steatohepatitis (Nash) Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (Nash)
  3.3.3 Labor Cost of Nonalcoholic Steatohepatitis (Nash)
3.4 Market Distributors of Nonalcoholic Steatohepatitis (Nash)
3.5 Major Downstream Buyers of Nonalcoholic Steatohepatitis (Nash) Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY TYPE

4.1 Global Nonalcoholic Steatohepatitis (Nash) Value and Market Share by Type (2015-2020)
4.2 Global Nonalcoholic Steatohepatitis (Nash) Production and Market Share by Type (2015-2020)
4.3 Global Nonalcoholic Steatohepatitis (Nash) Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Nonalcoholic Steatohepatitis (Nash) Value and Growth Rate of Weight Loss Treatment
  4.3.2 Global Nonalcoholic Steatohepatitis (Nash) Value and Growth Rate of Insulin-Sensitizing Agents
  4.3.3 Global Nonalcoholic Steatohepatitis (Nash) Value and Growth Rate of Lipid-Lowering Drugs
  4.3.4 Global Nonalcoholic Steatohepatitis (Nash) Value and Growth Rate of Antioxidants
  4.3.5 Global Nonalcoholic Steatohepatitis (Nash) Value and Growth Rate of Other Agents
4.4 Global Nonalcoholic Steatohepatitis (Nash) Price Analysis by Type (2015-2020)

5 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Market Share by Application (2015-2020)
5.3 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Phase I (2015-2020)
  5.3.2 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Phase II (2015-2020)
  5.3.3 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Phase III (2015-2020)
  5.3.4 Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Clinical Trials (2015-2020)

6 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY REGIONS

6.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Regions
  6.1.1 Global Nonalcoholic Steatohepatitis (Nash) Sales by Regions (2015-2020)
  6.1.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue by Regions (2015-2020)
6.2 North America Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
6.3 Europe Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
6.6 South America Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)

7 NORTH AMERICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Countries
  7.2.1 North America Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
  7.2.2 North America Nonalcoholic Steatohepatitis (Nash) Revenue by Countries (2015-2020)
7.3 United States Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
7.4 Canada Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
7.5 Mexico Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)

8 EUROPE NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Countries
  8.2.1 Europe Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
  8.2.2 Europe Nonalcoholic Steatohepatitis (Nash) Revenue by Countries (2015-2020)
8.3 Germany Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
8.4 UK Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
8.5 France Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
8.6 Italy Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
8.7 Spain Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
8.8 Russia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Nonalcoholic Steatohepatitis (Nash) Revenue by Countries (2015-2020)
9.3 China Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
9.4 Japan Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
9.5 South Korea Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
9.6 India Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
9.8 Australia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Revenue by Countries (2015-2020)
10.3 Saudi Arabia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
10.4 UAE Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
10.5 Egypt Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
10.6 Nigeria Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
10.7 South Africa Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Countries
  11.2.1 South America Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
  11.2.2 South America Nonalcoholic Steatohepatitis (Nash) Revenue by Countries (2015-2020)
11.3 Brazil Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
11.4 Argentina Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
11.5 Columbia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
11.6 Chile Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Tobira Therapeutics, Inc.
  12.1.1 Tobira Therapeutics, Inc. Basic Information
  12.1.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.1.3 Tobira Therapeutics, Inc. Production, Value, Price, Gross Margin 2015-2020
12.2 Cerenis Therapeutics
  12.2.1 Cerenis Therapeutics Basic Information
  12.2.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.2.3 Cerenis Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.3 Connexios Life Sciences
  12.3.1 Connexios Life Sciences Basic Information
  12.3.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.3.3 Connexios Life Sciences Production, Value, Price, Gross Margin 2015-2020
12.4 Verva Pharmaceuticals
  12.4.1 Verva Pharmaceuticals Basic Information
  12.4.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.4.3 Verva Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 GENFIT SA
  12.5.1 GENFIT SA Basic Information
  12.5.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.5.3 GENFIT SA Production, Value, Price, Gross Margin 2015-2020
12.6 Immuron Ltd
  12.6.1 Immuron Ltd Basic Information
  12.6.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.6.3 Immuron Ltd Production, Value, Price, Gross Margin 2015-2020
12.7 Galmed Pharmaceuticals Ltd.
  12.7.1 Galmed Pharmaceuticals Ltd. Basic Information
  12.7.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.7.3 Galmed Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2015-2020
12.8 Boehringer Ingelheim
  12.8.1 Boehringer Ingelheim Basic Information
  12.8.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.8.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.9 Novo Nordisk
  12.9.1 Novo Nordisk Basic Information
  12.9.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.9.3 Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
12.10 Enzo Biochem, Inc
  12.10.1 Enzo Biochem, Inc Basic Information
  12.10.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.10.3 Enzo Biochem, Inc Production, Value, Price, Gross Margin 2015-2020
12.11 Gilead Science
  12.11.1 Gilead Science Basic Information
  12.11.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.11.3 Gilead Science Production, Value, Price, Gross Margin 2015-2020
12.12 Viking Therapeutics
  12.12.1 Viking Therapeutics Basic Information
  12.12.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.12.3 Viking Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.13 Islet Sciences
  12.13.1 Islet Sciences Basic Information
  12.13.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.13.3 Islet Sciences Production, Value, Price, Gross Margin 2015-2020
12.14 Nimbus Therapeutics
  12.14.1 Nimbus Therapeutics Basic Information
  12.14.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.14.3 Nimbus Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.15 Intercepts Pharmaceuticals
  12.15.1 Intercepts Pharmaceuticals Basic Information
  12.15.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.15.3 Intercepts Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.16 Astazeneca Plc
  12.16.1 Astazeneca Plc Basic Information
  12.16.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.16.3 Astazeneca Plc Production, Value, Price, Gross Margin 2015-2020
12.17 Genfit
  12.17.1 Genfit Basic Information
  12.17.2 Nonalcoholic Steatohepatitis (Nash) Product Introduction
  12.17.3 Genfit Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST

14.1 Global Nonalcoholic Steatohepatitis (Nash) Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Weight Loss Treatment Market Value and Volume Forecast (2020-2025)
  14.1.2 Insulin-Sensitizing Agents Market Value and Volume Forecast (2020-2025)
  14.1.3 Lipid-Lowering Drugs Market Value and Volume Forecast (2020-2025)
  14.1.4 Antioxidants Market Value and Volume Forecast (2020-2025)
  14.1.5 Other Agents Market Value and Volume Forecast (2020-2025)
14.2 Global Nonalcoholic Steatohepatitis (Nash) Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Phase I Market Value and Volume Forecast (2020-2025)
  14.2.2 Phase II Market Value and Volume Forecast (2020-2025)
  14.2.3 Phase III Market Value and Volume Forecast (2020-2025)
  14.2.4 Clinical Trials Market Value and Volume Forecast (2020-2025)
14.3 Nonalcoholic Steatohepatitis (Nash) Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nonalcoholic Steatohepatitis (Nash)
Table Product Specification of Nonalcoholic Steatohepatitis (Nash)
Table Nonalcoholic Steatohepatitis (Nash) Key Market Segments
Table Key Players Nonalcoholic Steatohepatitis (Nash) Covered
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Size, 2015 – 2025
Table Different Types of Nonalcoholic Steatohepatitis (Nash)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) Segment by Type from 2015-2020
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Share by Types in 2019
Table Different Applications of Nonalcoholic Steatohepatitis (Nash)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) Segment by Applications from 2015-2020
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Share by Applications in 2019
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Share by Regions in 2019
Figure North America Nonalcoholic Steatohepatitis (Nash) Production Value ($) and Growth Rate (2015-2020)
Figure Europe Nonalcoholic Steatohepatitis (Nash) Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Nonalcoholic Steatohepatitis (Nash) Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Production Value ($) and Growth Rate (2015-2020)
Figure South America Nonalcoholic Steatohepatitis (Nash) Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Nonalcoholic Steatohepatitis (Nash)
Table Upstream Raw Material Suppliers of Nonalcoholic Steatohepatitis (Nash) with Contact Information
Table Major Players Headquarters, and Service Area of Nonalcoholic Steatohepatitis (Nash)
Figure Major Players Production Value Market Share of Nonalcoholic Steatohepatitis (Nash) in 2019
Table Major Players Nonalcoholic Steatohepatitis (Nash) Product Types in 2019
Figure Production Process of Nonalcoholic Steatohepatitis (Nash)
Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (Nash)
Figure Channel Status of Nonalcoholic Steatohepatitis (Nash)
Table Major Distributors of Nonalcoholic Steatohepatitis (Nash) with Contact Information
Table Major Downstream Buyers of Nonalcoholic Steatohepatitis (Nash) with Contact Information
Table Global Nonalcoholic Steatohepatitis (Nash) Value ($) by Type (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Value Share by Type (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value Share by Type (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Production by Type (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Production Share by Type (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Production Share by Type (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) and Growth Rate of Weight Loss Treatment (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) and Growth Rate of Insulin-Sensitizing Agents (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) and Growth Rate of Lipid-Lowering Drugs (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) and Growth Rate of Antioxidants (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Value ($) and Growth Rate of Other Agents (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Nonalcoholic Steatohepatitis (Nash) Consumption by Application (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Consumption Market Share by Application (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption Market Share by Application (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Phase I (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Phase II (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Phase III (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Consumption and Growth Rate of Clinical Trials (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) and Growth (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales by Regions (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Regions (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) by Regions (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Regions (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Regions in 2015
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Regions in 2019
Figure North America Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Europe Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure South America Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) and Growth (2015-2020)
Table North America Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
Table North America Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Countries (2015-2020)
Table North America Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) by Countries (2015-2020)
Table North America Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Countries (2015-2020)
Figure United States Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Canada Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Mexico Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) and Growth (2015-2020)
Table Europe Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
Table Europe Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Countries (2015-2020)
Table Europe Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) by Countries (2015-2020)
Table Europe Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Countries (2015-2020)
Figure Germany Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure UK Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure France Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Italy Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Spain Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Russia Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
Table Asia Pacific Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Countries (2015-2020)
Table Asia Pacific Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Countries (2015-2020)
Figure China Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Japan Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure South Korea Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure India Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Southeast Asia Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Australia Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Middle East Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) and Growth (2015-2020)
Table Middle East Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
Table Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure UAE Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Egypt Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Nigeria Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure South Africa Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure South America Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) and Growth (2015-2020)
Table South America Nonalcoholic Steatohepatitis (Nash) Sales by Countries (2015-2020)
Table South America Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Countries (2015-2020)
Table South America Nonalcoholic Steatohepatitis (Nash) Revenue (M USD) by Countries (2015-2020)
Table South America Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Countries (2015-2020)
Figure Brazil Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Argentina Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Figure Columbia Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Chile Nonalcoholic Steatohepatitis (Nash) Sales and Growth (2015-2020)
Figure Top 3 Market Share of Nonalcoholic Steatohepatitis (Nash) Companies in 2019
Figure Top 6 Market Share of Nonalcoholic Steatohepatitis (Nash) Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Tobira Therapeutics, Inc. Profile
Table Tobira Therapeutics, Inc. Product Introduction
Figure Tobira Therapeutics, Inc. Production and Growth Rate
Figure Tobira Therapeutics, Inc. Value ($) Market Share 2015-2020
Table Cerenis Therapeutics Profile
Table Cerenis Therapeutics Product Introduction
Figure Cerenis Therapeutics Production and Growth Rate
Figure Cerenis Therapeutics Value ($) Market Share 2015-2020
Table Connexios Life Sciences Profile
Table Connexios Life Sciences Product Introduction
Figure Connexios Life Sciences Production and Growth Rate
Figure Connexios Life Sciences Value ($) Market Share 2015-2020
Table Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Product Introduction
Figure Verva Pharmaceuticals Production and Growth Rate
Figure Verva Pharmaceuticals Value ($) Market Share 2015-2020
Table GENFIT SA Profile
Table GENFIT SA Product Introduction
Figure GENFIT SA Production and Growth Rate
Figure GENFIT SA Value ($) Market Share 2015-2020
Table Immuron Ltd Profile
Table Immuron Ltd Product Introduction
Figure Immuron Ltd Production and Growth Rate
Figure Immuron Ltd Value ($) Market Share 2015-2020
Table Galmed Pharmaceuticals Ltd. Profile
Table Galmed Pharmaceuticals Ltd. Product Introduction
Figure Galmed Pharmaceuticals Ltd. Production and Growth Rate
Figure Galmed Pharmaceuticals Ltd. Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Novo Nordisk Profile
Table Novo Nordisk Product Introduction
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Table Enzo Biochem, Inc Profile
Table Enzo Biochem, Inc Product Introduction
Figure Enzo Biochem, Inc Production and Growth Rate
Figure Enzo Biochem, Inc Value ($) Market Share 2015-2020
Table Gilead Science Profile
Table Gilead Science Product Introduction
Figure Gilead Science Production and Growth Rate
Figure Gilead Science Value ($) Market Share 2015-2020
Table Viking Therapeutics Profile
Table Viking Therapeutics Product Introduction
Figure Viking Therapeutics Production and Growth Rate
Figure Viking Therapeutics Value ($) Market Share 2015-2020
Table Islet Sciences Profile
Table Islet Sciences Product Introduction
Figure Islet Sciences Production and Growth Rate
Figure Islet Sciences Value ($) Market Share 2015-2020
Table Nimbus Therapeutics Profile
Table Nimbus Therapeutics Product Introduction
Figure Nimbus Therapeutics Production and Growth Rate
Figure Nimbus Therapeutics Value ($) Market Share 2015-2020
Table Intercepts Pharmaceuticals Profile
Table Intercepts Pharmaceuticals Product Introduction
Figure Intercepts Pharmaceuticals Production and Growth Rate
Figure Intercepts Pharmaceuticals Value ($) Market Share 2015-2020
Table Astazeneca Plc Profile
Table Astazeneca Plc Product Introduction
Figure Astazeneca Plc Production and Growth Rate
Figure Astazeneca Plc Value ($) Market Share 2015-2020
Table Genfit Profile
Table Genfit Product Introduction
Figure Genfit Production and Growth Rate
Figure Genfit Value ($) Market Share 2015-2020
Table Market Driving Factors of Nonalcoholic Steatohepatitis (Nash)
Table Merger, Acquisition and New Investment
Table Global Nonalcoholic Steatohepatitis (Nash) Market Value ($) Forecast, by Type
Table Global Nonalcoholic Steatohepatitis (Nash) Market Volume Forecast, by Type
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Value ($) and Growth Rate Forecast of Weight Loss Treatment (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Volume ($) and Growth Rate Forecast of Weight Loss Treatment (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Value ($) and Growth Rate Forecast of Insulin-Sensitizing Agents (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Volume ($) and Growth Rate Forecast of Insulin-Sensitizing Agents (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Value ($) and Growth Rate Forecast of Lipid-Lowering Drugs (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Volume ($) and Growth Rate Forecast of Lipid-Lowering Drugs (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Value ($) and Growth Rate Forecast of Antioxidants (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Volume ($) and Growth Rate Forecast of Antioxidants (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Value ($) and Growth Rate Forecast of Other Agents (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Volume ($) and Growth Rate Forecast of Other Agents (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Phase I (2020-2025)
Figure Market Volume and Growth Rate Forecast of Phase I (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Phase II (2020-2025)
Figure Market Volume and Growth Rate Forecast of Phase II (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Phase III (2020-2025)
Figure Market Volume and Growth Rate Forecast of Phase III (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Clinical Trials (2020-2025)
Figure Market Volume and Growth Rate Forecast of Clinical Trials (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery